Sunday, March 9, 2014

Southwestern Athletic conference tournament

This is part 20 of a 32-part series covering each conference and conference tournament.  These previews are meant to provide every bracketologist with the information they need to make informed projections about the teams of the conference.

The standings:
Southern 15-3
Texas Southern 12-6
Alabama St 12-6
Arkansas-Pine Bluff 11-7
Alabama A&M 10-8
Alcorn St 9-9
Jackson St 7-11
Prairie View A&M 6-12
Mississippi Valley St 5-13
Grambling St 3-15

Tournament format:
Ok, this is where it gets weird.

4 teams got APR'd and ruled ineligible this year:  UAPB, Grambling, MVSU, and Southern.  However, instead of running a conference tournament with 6 eligible teams, the SWAC got a waiver.  All 10 teams are playing this shindig.  The conference's automatic bid will go to the team that goes farthest in the tournament while being eligible.  So that's....something.  If there's a tie (i.e., two ineligible teams make it to the finals), the team with the higher seed gets the bid.

Now, it's worth noting the four ineligible teams are seeded 1, 4, 9, and 10.  Let's assume 9 and 10 lose early.  If seeds holds the 1/4 matchup will be a semifinal between two ineligible teams, and the 2/3 semifinal would actually be for the NCAA bid.

Tournament is March 11-15.  First round March 11, quarterfinals on the 12th and 13th, semis on the 14th, finals on the 15th.  Houston is your neutral site host.

The matchups:
8) Prairie View A&M (8-22) vs. 9) Mississippi Valley St (9-22)
7) Jackson St (11-19) vs. 10) Grambling St (4-23)

1) Southern (19-12) vs. 8/9 winner
4) Arkansas-Pine Bluff (13-17) vs. 5) Alabama A&M (13-15)
3) Alabama St (18-11) vs. 6) Alcorn St (12-18)
2) Texas Southern (16-14) vs. 7/10 winner

The stakes:
Whoever gets the bid goes to Dayton.  As mentioned above, the situation is a bit weird.  So pay attention to the potential Alabama St/Texas Southern showdown.  Good chance that'll be for the autobid

TSU and ASU are CBI/CIT eligible, but I doubt we see either in them.

No comments: